Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Reply: New confounders emerging with new evidence regarding reduced HCC and improved survival

Published:2024-06-05 Issue: Volume: Page:
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:

Author:

Jeng Wen-Juei¹²^ORCID,Chien Rong-Nan¹²³^ORCID,Liaw Yun-Fan¹³^ORCID

Affiliation:

1. College of Medicine, Chang Gung University, Taipei, Taiwan

2. Department of Gastroenterology and Hepatology, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan

3. Liver Research Unit, Chang Gung Memorial Hospital, Taoyuan, Taiwan

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference5 articles.

1. Letter to the editor: New confounders emerging with new evidence regarding reduced HCC and improved survival;Hu;Hepatology,2024

2. Hepatocellular carcinoma reduced, HBsAg loss increased and survival improved after finite therapy in hepatitis B patients with cirrhosis;Jeng;Hepatology,2024

3. Association of metformin use and cancer incidence: A systematic review and meta-analysis;O’Connor;J Natl Cancer Inst,2024

4. Association of GLP-1 receptor agonists and hepatocellular carcinoma incidence and hepatic decompensation in patients with type 2 diabetes;Wang;Gastroenterology,2024

5. Impacts of glucagon-like peptide-1 receptor agonists on the risk of adverse liver outcomes in patients with metabolic dysfunction-associated steatotic liver disease cirrhosis and type 2 diabetes;Elsaid;Aliment Pharmacol Ther,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP